RESMED INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 357,985 | $80,134,942 | 1.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2025 |
| June 30, 2025 | 324,279 | $83,663,982 | 1.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 30, 2025 |
| Sept. 30, 2025 | 285,019 | $78,018,251 | 1.01% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2025 |
| Dec. 31, 2025 | 273,388 | $65,850,968 | 0.86% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 5, 2026 |
| March 31, 2026 | 272,553 | $61,182,697 | 0.84% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 28, 2026 |
| June 30, 2026 | 45,984 | $8,961,362 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.